Search results
Showing 16 to 30 of 201 results for dementia
aggression and distress in people living with dementia Enteral (tube) feeding for people living with severe dementia...
This quality standard covers diagnosing, assessing and treating community-acquired and hospital-acquired pneumonia in babies over 1 month (corrected gestational age), children, young people and adults. It describes high-quality care in priority areas for improvement. It does not cover ventilator associated pneumonia or COVID-19 pneumonia.
View quality statements for QS110Show all sections
Sections for QS110
Bed frames for adults in acute medical or surgical hospital wards: late-stage assessment (HTG759)
Late stage assessment (LSA) guidance on bed frames for adults in acute medical or surgical hospital wards.
IMI and H2020 Grant funded projects with NICE
mum, Shazia is overwhelmed as she also cares for her own mother who has dementia. Mental health services Managing violence and...
(guideline CG170). Dementia Supporting people with dementia and their carers in health and social care (guideline CG42)...
The benefits from donanemab (also called Kisunla and made by Eli Lilly) and lecanemab (also called Leqembi and made by Eisai) - remain too small to justify the additional cost to the NHS, one of our independent committees has concluded following consultation.
the Quality Outcomes Framework (QOF). 2010 First quality standard QS1 Dementia: support in health and social care (March). Read more...
that she feels overwhelmed as she is a carer for her own mother, who has dementia and lives with them in the family home. Action...
conditions guideline People's experience in adult social care guideline Dementia guideline Care of dying adults guideline Home care...
mum, Shazia, is overwhelmed as she also cares for her own mother who has dementia. Back to top
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19 (TA878)
Evidence-based recommendations on nirmatrelvir plus ritonavir (Paxlovid), sotrovimab (Xevudy) and tocilizumab (RoActemra) for treating COVID-19.
This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.